EX-23.1 2 s002128x1_ex23-1.htm EXHIBIT 23.1

Exhibit 23.1
 
Consent of Independent Registered Public Accounting Firm

The Board of Directors
Aquestive Therapeutics, Inc.:
 
We consent to the incorporation by reference in this Registration Statement on Form S-1 filed pursuant to Rule 462(b) of the Securities Act of 1933, as amended, of our report dated April 2, 2018, included in the Registration Statement on Form S-1 (No. 333-225924), as amended, and to the reference to our firm under the heading “Experts” in the prospectus included in such Registration Statement.
 
/s/ KPMG LLP
 
New York, New York
July 24, 2018